Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 4 1Phase 3 1Phase 1 1

Status

Completed 4Unknown 1Terminated 1

Sponsor Class

OTHER 5INDUSTRY 1

Study Type

Interventional 6Observational 2

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Influenza, Human 13Neoplasms 6Colorectal Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Leukemia, Myeloid, Acute 3Leukemia, Lymphocytic, Chronic, B-Cell 3Recurrence 2Pancreatic Neoplasms 2Neuroblastoma 2Myelodysplastic Syndromes 2Multiple Myeloma 2Melanoma 2Lymphoma, Non-Hodgkin 2Lymphoma 2Leukemia 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Waldenstrom Macroglobulinemia 1Virus Diseases 1Vaccine-Preventable Diseases 1Vaccination Hesitancy 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Patient Acceptance of Health Care 1Ovarian Neoplasms 1Osteosarcoma 1

Interventions

pembrolizumab 180Gemcitabine 168Paclitaxel 150Carboplatin 134Bevacizumab 126Cisplatin 113Docetaxel 112Cyclophosphamide 109Exercise 97Nivolumab 92Fluorouracil 88Capecitabine 85Dexamethasone 81Irinotecan 74Radiotherapy 68Oxaliplatin 68Pemetrexed 66Standard of Care 64Leucovorin 63Cetuximab 59Sorafenib 53Erlotinib Hydrochloride 53Drug Therapy 53Blood Specimen Collection 52Doxorubicin 50trametinib 47atezolizumab 47Ipilimumab 47Albumin-Bound Paclitaxel 44130-nm albumin-bound paclitaxel 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Interventional × Neoplasms × Influenza Vaccines × Clear all
NCT02860039 2024-10-22

High Dose Flu Vaccine in Treating Children Who Have Undergone Donor Stem Cell Transplant

Vanderbilt-Ingram Cancer Center

Phase 2 Completed
170 enrolled 11 charts

Influenza, Human, Neoplasms

NCT01695733 2018-08-31

Response to Influenza Vaccine in Patients With Non-Hematologic Malignancies Receiving Chemotherapy

Washington University School of Medicine

Phase 1 Terminated
21 enrolled
Tumor-Agnostic

Neoplasms

NCT01205581 2016-09-23

Immunogenicity of Fluzone HD,A High Dose Influenza Vaccine, In Children With Cancer or HIV

St. Jude Children's Research Hospital

Phase 2 Completed
85 enrolled 24 charts

Influenza, Human, Neoplasms

NCT01666782 2016-06-24

IMMUNE

Rochester General Hospital

Phase 2 Completed
105 enrolled 10 charts

Influenza, Human, Neoplasms

NCT01698177 2013-04-19

Optimizing Influenza Vaccination in Surgical Oncology Patients

Stony Brook University

Phase 4 Unknown
204 enrolled

Influenza, Human, Neoplasms

NCT01031719 2012-09-13

Clinical Trial to Compare the Immunogenicity, Safety, and Tolerability of an Adjuvanted A(H1N1) Influenza Vaccine Versus Non-Adjuvanted A(H1N1) Influenza Vaccines in Patients With Invasive Solid Tumors

Chiltern Pesquisa Clinica Ltda

Phase 3 Completed
59 enrolled

Influenza, Human, Neoplasms, Virus Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡